Heseltine P N, Yellin A E, Appleman M D, Gill M A, Chenella F C, Kern J W, Berne T V
J Infect Dis. 1983 Aug;148(2):322-9. doi: 10.1093/infdis/148.2.322.
The relationships between resistant pathogens, serum levels of gentamicin, and the outcomes of gangrenous or perforated appendicitis were analyzed in 147 patients. Failure to cure the infection occurred significantly more frequently among patients treated with cefoperazone or cefamandole than among those treated with clindamycin and gentamicin in combination. The failures were associated with recovery of resistant Bacteroides fragilis from intraoperative cultures. Pseudomonas species were also associated with failures, their in vitro susceptibility not correlating with clinical cure. Patients with gentamicin peak serum levels of less than 6 micrograms/ml in the first three days were not more likely to be associated with failure than were patients with higher levels. These clinical observations indicate that antibiotic therapy of intra-abdominal sepsis should include antibiotics with in vitro activity against B fragilis and that precise adjustments of gentamicin levels may not improve outcome. In addition, Pseudomonas species may play a significant role in some of these infections.
对147例坏疽性或穿孔性阑尾炎患者分析了耐药病原体、庆大霉素血清水平与治疗结果之间的关系。与联合使用克林霉素和庆大霉素治疗的患者相比,使用头孢哌酮或头孢孟多治疗的患者感染未能治愈的情况明显更频繁。治疗失败与术中培养出耐药脆弱拟杆菌有关。假单胞菌属也与治疗失败有关,其体外药敏情况与临床治愈情况不相关。前三天庆大霉素血清峰值水平低于6微克/毫升的患者与水平较高的患者相比,治疗失败的可能性并不更高。这些临床观察结果表明,腹腔内脓毒症的抗生素治疗应包括对脆弱拟杆菌具有体外活性的抗生素,精确调整庆大霉素水平可能无法改善治疗结果。此外,假单胞菌属可能在其中一些感染中起重要作用。